Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update

E-ISSN： 1873-5576|18|9|857-868

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.18, Iss.9, 2018-11, pp. : 857-868

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody-based cancer therapy

By Baxevanis Constantin N

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

By Bernard-Marty Chantal Lebrun Fabienne Awada Ahmad Piccart Martine J.

Drugs, Vol. 66, Iss. 12, 2006-01 ,pp. : 1577-1591

Adis International

Access to resources Recommend Favorite

Antibody-based antiangiogenic cancer therapy

By Sanz Laura Álvarez-Vallina Luis

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1235-1245

Informa Healthcare

Access to resources Recommend Favorite

Antibody Engineering for Targeted Therapy of Cancer Recombinant Fv-Immunotoxins

Current Pharmaceutical Biotechnology, Vol. 2, Iss. 1, 2001-03 ,pp. : 19-46

Bentham Science Publishers

Access to resources Recommend Favorite

Antibody-Targeted RNase Fusion Proteins (ImmunoRNases) for Cancer Therapy

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 3, 2008-06 ,pp. : 231-234

Bentham Science Publishers

Access to resources Recommend Favorite